In particular for tracking deployment in complex supply chains with complex data.
How AI is Helping with COVID-19 Vaccine Rollout and Tracking
December 17
Covid-19 Coronavirus Vaccine vials in a row macro close up in AITrends By John P. Desmond, AI Trends Editor
AI has been employed since the early days of the COVID-19 pandemic to track the spread of positive cases, to crunch through thousands of scientific papers to search for treatment options and to help develop a vaccine. Now AI and other digital tools are being deployed to manage complex supply chains for the vaccine.
With the third highest number of coronavirus cases in Europe after France and Italy, according to data from Johns Hopkins University, the UK is the first country to distribute the Pfizer vaccine. The UK has 1.7 million confirmed cases in a population of close to 68 million people, Tracking side effects from the vaccine rollout is a huge task, UK health officials have said, according to an account from Nasdaq. To help meet the challenge, the UK Medicines & Healthcare products Regulatory Agency (MHRA) recently partnered with the UK unit of Genpact, the global professional services firm specializing in digital transformation. The company is integrating components of its AI software suite with the government’s website where adverse effects are reported.
“When a vaccine gets distributed at scale and speed, a technology solution needs to track the batch and lot numbers to know exactly where each dose is and who received it,” stated Eric Sandor, drug safety AI lead at Genpact. “There’s a lot of information, in a number of different formats, and it’s very manually intensive to try to codify it in a way that makes sense. AI will help with processing all that data faster than humans can. It’s quite complicated at scale, but is a critical element to overall public health.” ... '
No comments:
Post a Comment